IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 239 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,453,734 | +56.1% | 319,502 | +141.6% | 0.17% | +10.4% |
| Q2 2023 | $931,033 | +158.6% | 132,249 | +124.4% | 0.15% | +105.3% |
| Q1 2023 | $360,026 | -73.2% | 58,924 | -72.0% | 0.08% | -78.6% |
| Q4 2022 | $1,344,456 | +173.8% | 210,400 | +310.9% | 0.35% | +258.2% |
| Q3 2022 | $491,000 | -58.0% | 51,206 | -51.6% | 0.10% | -79.2% |
| Q2 2022 | $1,168,000 | +244.5% | 105,780 | +418.9% | 0.47% | +946.7% |
| Q1 2022 | $339,000 | -78.7% | 20,386 | -68.4% | 0.04% | -70.6% |
| Q3 2021 | $1,592,000 | -4.3% | 64,556 | +0.9% | 0.15% | -34.3% |
| Q2 2021 | $1,664,000 | +545.0% | 63,956 | +580.6% | 0.23% | +23.3% |
| Q2 2020 | $258,000 | -17.0% | 9,397 | -66.0% | 0.19% | +894.7% |
| Q3 2018 | $311,000 | – | 27,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,222,701 | $25,005,000 | 8.92% |
| Broadfin Capital, LLC | 4,894,361 | $55,062,000 | 8.10% |
| GREAT POINT PARTNERS LLC | 3,496,340 | $39,334,000 | 6.13% |
| FRAZIER MANAGEMENT LLC | 2,188,331 | $24,619,000 | 4.51% |
| Prosight Management, LP | 715,317 | $8,047,000 | 4.49% |
| Avoro Capital Advisors LLC | 8,662,720 | $97,456,000 | 4.48% |
| QVT Financial LP | 821,361 | $8,748,000 | 2.26% |
| Perceptive Advisors | 7,290,199 | $82,014,000 | 2.19% |
| Rhenman & Partners Asset Management AB | 1,290,495 | $14,518,000 | 1.46% |
| EMORY UNIVERSITY | 185,915 | $2,092,000 | 1.37% |